A Phase 2/3 clinical trial of SZN-043 for the treatment of severe alcohol-associated hepatitis
Latest Information Update: 02 Apr 2024
At a glance
- Drugs SZN 043 (Primary)
- Indications Alcoholic hepatitis
- Focus Therapeutic Use
Most Recent Events
- 02 Apr 2024 New trial record